Guanabenz Blood Pressure Drug Protects Against MS Symptoms In Animal Models

Guanabenz is an FDA-approved drug for high blood pressure but a new study also finds that it prevents myelin loss and alleviates clinical symptoms of multiple sclerosis (MS) in animal models. The drug appears to enhance an innate cellular mechanism that protects myelin-producing cells against inflammatory stress. Multiple sclerosis is characterized by an abnormal immune response that leads to inflammation in the brain and the destruction of myelin - a fatty sheath that protects and insulates nerve fibers. MS is thought to affect more than 2.3 million people worldwide and has no known cure. read more

Read the whole article on

More from